scispace - formally typeset
A

Ao Li

Researcher at Xiamen University

Publications -  22
Citations -  470

Ao Li is an academic researcher from Xiamen University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 9, co-authored 15 publications receiving 237 citations.

Papers
More filters
Journal ArticleDOI

Composition Tunable Manganese Ferrite Nanoparticles for Optimized T2 Contrast Ability

TL;DR: In this article, the effects of manganese doping on changes of ferrite crystal structures, magnetic properties, and contrast abilities were investigated, and a successful one-pot synthesis of uniform manganized-doped magnetite (MnxFe3-xO4) nanoparticles with different manganous contents (x = 0.06).
Journal ArticleDOI

The Roles of Morphology on the Relaxation Rates of Magnetic Nanoparticles

TL;DR: The surface-area-to-volume ratio and the amount of effective metal ions on exposed surface are instrumental for tuning positive contrast abilities and could serve as guidelines for design and development of high-performance nanoparticle-based contrast agents.
Journal ArticleDOI

Versatile Octapod-Shaped Hollow Porous Manganese(II) Oxide Nanoplatform for Real-Time Visualization of Cargo Delivery.

TL;DR: This octapod-shaped Cargo@HPMO can act as a smart and versatile nanoplatform with pH-responsive multimodal imaging and site-specific drug delivery for the development of accurate diagnosis and effective therapy for cancer.
Journal ArticleDOI

Cascaded Multiresponsive Self-Assembled 19F MRI Nanoprobes with Redox-Triggered Activation and NIR-Induced Amplification.

TL;DR: A cascaded multiresponsive self-assembled nanoprobe is reported, which enables sequential redox-triggered and near infrared (NIR) irradiation-induced 19F MR signal activation/amplification for sensing and imaging.
Journal ArticleDOI

A gadolinium-complex-based theranostic prodrug for in vivo tumour-targeted magnetic resonance imaging and therapy

TL;DR: A target-specific theranostic prodrug containing Gd-DOTA, biotin, and camptothecin along with a disulfide self-immolative linker exhibits selective targeting towards tumour cells and tissues, stimuli-responsive controlled release, enhanced anticancer efficacy, and accurate diagnosis and real-time monitoring via contrast-enhanced magnetic resonance imaging (MRI).